Mr Deighan is responsible for all aspects of InnoPharma’s finance, accounting, planning, treasury and administrative functions.
Prior to joining InnoPharma, Mr. Deighan was chief financial officer of Eagle Pharmaceuticals, a hospital specialty company focused on reformulating and improving injectable drugs. Mr. Deighan established the financial and administrative functions of Eagle, and participated in the negotiation of licensing and financing deals for the Company, in addition to his involvement in various strategic and operational decisions of the company. Previously, Mr. Deighan held the position of corporate controller at Orchid Cellmark, a DNA testing services laboratory and of divisional controller at Alpharma, a diversified global pharmaceutical company. Mr. Deighan received a Bachelor of Science in business administration from the State University of New York at Oswego, and is a certified public accountant.